Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alpha 1-Antitrypsin Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00005098
What this trial is testing

Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
National Center for Research Resources (NCRR) 160
Not applicableStudy completedNCT01862211
What this trial is testing

Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort

Who this might be right for
Children With a Deficiency of Alpha-1 Antitrypsin
Hospices Civils de Lyon 296
Large-scale testing (Phase 3)Study completedNCT00460096
What this trial is testing

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Kamada, Ltd. 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05899673
What this trial is testing

An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease

Who this might be right for
Alpha1-Antitrypsin Deficiency
Takeda 31
Testing effectiveness (Phase 2)WithdrawnNCT05146882
What this trial is testing

An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATLD)

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Testing effectiveness (Phase 2)Study completedNCT02168686
What this trial is testing

Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Adverum Biotechnologies, Inc. 6
Not applicableEnrolling By InvitationNCT00884455
What this trial is testing

Alpha-1 Foundation DNA and Tissue Bank

Who this might be right for
Alpha 1 Antitrypsin Deficiency
University of Florida 5,000
Not applicableStudy completedNCT01380626
What this trial is testing

Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAlpha-1-antitrypsin-deficiency
Schön Klinik Berchtesgadener Land 20
Post-approval studies (Phase 4)Looking for participantsNCT07135427
What this trial is testing

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

Who this might be right for
Alpha 1-AntitrypsinCOPDAntibody Deficiency
University of Alabama at Birmingham 30
Testing effectiveness (Phase 2)Study completedNCT04722887
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

Who this might be right for
Alpha1-Antitrypsin Deficiency
Grifols Therapeutics LLC 17
Not applicableStudy completedNCT02691611
What this trial is testing

Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
National Jewish Health 39
Not applicableLooking for participantsNCT07152834
What this trial is testing

Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction

Who this might be right for
Alpha 1-antitrypsin Deficiency (AATD)
Muğla Sıtkı Koçman University 734
Not applicableStudy completedNCT02810327
What this trial is testing

Alpha-1 Carrier Genomics Study

Who this might be right for
Alpha-1 Antitrypsin DeficiencyEmphysemaCOPD+1 more
Medical University of South Carolina 117
Not applicableActive Not RecruitingNCT02014415
What this trial is testing

Alpha-1 Antitrypsin Deficiency Adult Liver Study

Who this might be right for
Alpha-1 Antitrypsin Deficiency
St. Louis University 120
Not applicableStudy completedNCT00499941
What this trial is testing

Alpha-1 Foundation Research Registry

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Medical University of South Carolina 6,655
Not applicableUnknownNCT02929940
What this trial is testing

Liver Disease in Patients With alpha1-antitrypsin Deficiency

Who this might be right for
alpha1-antitrypsin Deficiency
RWTH Aachen University 500
Not applicableLooking for participantsNCT04157049
What this trial is testing

Alpha-1 Research Registry

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Alpha-1 Foundation 5,000
Early research (Phase 1)Ended earlyNCT04443192
What this trial is testing

A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiXZ Subjects

Who this might be right for
Alpha1 Anti-Trypsin Deficiency
Z Factor Limited 69
Testing effectiveness (Phase 2)Study completedNCT04474197
What this trial is testing

Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype

Who this might be right for
Alpha1-Antitrypsin Deficiency
Vertex Pharmaceuticals Incorporated 44
Post-approval studies (Phase 4)Study completedNCT00261833
What this trial is testing

Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency

Who this might be right for
Alpha1-proteinase Inhibitor DeficiencyEmphysema
CSL Behring 180
Next Page